Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for prevention of postoperative cognitive dysfunction after total knee replacement in older adults
ChiCTR2100050424Phase 4Suspended
- Sponsor
- Fujian Provincial Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluoxetine in post-operative cognitive decline (POCD), sponsored by Fujian Provincial Hospital. Primary endpoint: Incidence of postoperative cognitive dysfunction. Started May 2022; status: suspended.
02
Drugs
fluoxetine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2100050424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050424.